New York State Teachers Retirement System Has $9.68 Million Holdings in Align Technology, Inc. $ALGN

New York State Teachers Retirement System lessened its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 0.9% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 51,127 shares of the medical equipment provider’s stock after selling 447 shares during the period. New York State Teachers Retirement System owned 0.07% of Align Technology worth $9,680,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of ALGN. Cromwell Holdings LLC grew its holdings in Align Technology by 2,900.0% during the 2nd quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock worth $34,000 after acquiring an additional 174 shares during the period. Center for Financial Planning Inc. acquired a new position in shares of Align Technology in the 1st quarter valued at about $35,000. SVB Wealth LLC bought a new stake in shares of Align Technology during the 1st quarter valued at about $36,000. Farther Finance Advisors LLC grew its stake in Align Technology by 42.2% during the second quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider’s stock worth $59,000 after purchasing an additional 92 shares during the period. Finally, Mather Group LLC. increased its holdings in Align Technology by 375.0% in the first quarter. Mather Group LLC. now owns 437 shares of the medical equipment provider’s stock worth $69,000 after purchasing an additional 345 shares in the last quarter. Institutional investors own 88.43% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on ALGN. UBS Group reduced their price target on shares of Align Technology from $160.00 to $155.00 and set a “neutral” rating for the company in a report on Thursday. Wells Fargo & Company reduced their target price on Align Technology from $246.00 to $199.00 and set an “overweight” rating for the company in a research note on Thursday, July 31st. Morgan Stanley reaffirmed an “equal weight” rating and set a $154.00 price target (down from $249.00) on shares of Align Technology in a research note on Thursday, July 31st. Zacks Research upgraded Align Technology from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 30th. Finally, Stifel Nicolaus reduced their price objective on Align Technology from $275.00 to $200.00 and set a “buy” rating for the company in a research note on Thursday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Align Technology currently has an average rating of “Hold” and a consensus target price of $182.67.

Align Technology Price Performance

ALGN opened at $130.45 on Monday. Align Technology, Inc. has a fifty-two week low of $122.00 and a fifty-two week high of $246.19. The firm has a market capitalization of $9.46 billion, a PE ratio of 22.00, a P/E/G ratio of 1.48 and a beta of 1.70. The company’s 50-day moving average is $134.71 and its 200 day moving average is $163.36.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.57 by ($0.08). The company had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1.06 billion. Align Technology had a net margin of 11.04% and a return on equity of 13.36%. Align Technology’s revenue for the quarter was down 1.6% on a year-over-year basis. During the same quarter last year, the firm posted $2.41 EPS. Align Technology has set its Q3 2025 guidance at EPS. As a group, analysts expect that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology announced that its board has initiated a stock buyback program on Tuesday, August 5th that permits the company to repurchase $200.00 million in shares. This repurchase authorization permits the medical equipment provider to buy up to 2% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board of directors believes its stock is undervalued.

Insider Transactions at Align Technology

In related news, CEO Joseph M. Hogan purchased 7,576 shares of the stock in a transaction that occurred on Friday, August 1st. The stock was acquired at an average cost of $131.49 per share, with a total value of $996,168.24. Following the transaction, the chief executive officer owned 184,945 shares of the company’s stock, valued at $24,318,418.05. This represents a 4.27% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.66% of the company’s stock.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.